Adjuvant FOLFOX treatment for stage III colon cancer: how many cycles are enough?

PURPOSE: Adjuvant FOLFOX (5-fluorouracil and oxaliplatin) chemotherapy benefits stage III colon cancer patients. However, it still results in side effects and increased cost. Reducing cycles had been thought to decrease these problems. This retrospective study aimed to find the appropriate number of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Springerplus
Main Authors: Tsai, Yi-Jian, Lin, Jen-Kou, Chen, Wei-Shone, Jiang, Jeng-Kai, Teng, Hao-Wei, Yen, Chueh-Chuan, Lin, Tzu-chen, Yang, Shung-Haur
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4980863/
https://ncbi.nlm.nih.gov/pubmed/27563513
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40064-016-2976-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados